|
SEQ_NO
|
3
|
Date of announcement
|
2021/03/13
|
Time of announcement
|
17:53:33
|
|
Subject
|
Announcement major subsidiary Cotton Field Organic Co.,Ltd. of 2021 Shareholder’s Meeting
to approve the release of non-compete restrictions for the directors
|
||||
|
Date of events
|
2021/04/09
|
To which item it meets
|
paragraph 21
|
||
|
Statement
|
1.Date of the shareholders’ meeting resolution:2021/04/09
2.Name and title of the managerial officer with permission
to engage in competitive conduct:
(1)Director:Microbio Co.,Ltd.
(2)Director:Shan Ney, Huang.Juristic-person director of Microbio Co.,Ltd.
(3)Director:Xiang-Chun,Weng.
(4)Director:Chi-Wen,Luo.Juristic-person director of Microbio Co.,Ltd.
(5)Director:Jing-Quan,Lu.Juristic-person director of Microbio Co.,Ltd.
(6)Director:Yitai Investment Co., Ltd
(7)Director:Zhi-Quan,Chen.Juristic-person director of Yitai Investment Co.,
Ltd
3.Items of competitive conduct in which the officer is
permitted to engage:
(1)Director：Microbio Co.,Ltd.
Diamond Biofund Inc./Chairman
Microsoy International Inc./Chairman and Director
Sun Biofund Inc./Chairman
Oneness Biotech Co., Ltd./Director
Microbio (Shanghai) Co., Ltd./Chairman and Director
(2)Director:Shan Ney, Huang.Juristic-person director of Microbio Co.,Ltd.
Harmony Organic Agriculture Foundation/Chairman
Oneness Biotech Co., Ltd./Chairman and President
Microbio Co.,Ltd./Juristic-person chairman of Microbio Co.,Ltd. and
President
(3)Director:Xiang-Chun,Weng.
Deeksha Organic Enterprise Co., Ltd./Director
Xiangchun Biomass Business Co., Ltd./Director
Prosperity Co., Ltd./Director
(4)Director：Chi-Wen,Luo.Juristic-person director of Microbio Co.,Ltd.
Cotton Field Organic Farm Inc./Juristic-person Director
(5)Director:Jing-Quan,Lu.Juristic-person director of Microbio Co.,Ltd.
Harmony Organic Agriculture Foundation/Director
(6)Director:Yitai Investment Co., Ltd
OBI Pharma, Inc./Director
CHO Pharma, Inc./Director
(7)Director:Zhi-Quan,Chen.Juristic-person director of Yitai Investment Co.,
Ltd
Amaran Biotechnology Inc./Juristic-person Director
Mithra Biotechnology Inc./Juristic-person Director
Mass Solutions Technology/Juristic-person Director
Tanvex Biologics, Inc./Juristic-person Director
Tanvex BioPharma,Inc./Juristic-person Director
CHO Pharma, Inc./Juristic-person Director
TaiMed Biologics Inc./Juristic-person Director
Mithra Chemical Analysis Laboratory Inc./Juristic-person Director
RenBio, Inc./Juristic-person Director
OBI Pharma, Inc./Juristic-person Director
Miho International Cosmetic Co., Ltd./Juristic-person Director
RenBio Holdings/Juristic-person Director
Theragent, Inc./Juristic-person Director
Delos Capital Holdings Limited/Juristic-person Director
Gogoro Inc./Juristic-person Director
Do-Intelligent Consulting Inc./Juristic-person Director
4.Period of permission to engage in the competitive conduct:
Within period serving as a director in the Company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 209 of the
Company Act):
Unanimous approval from all presented shareholders upon chairman’s inquiry.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the directors (if it is not the operator of
a mainland China enterprise, please enter “N/A” below):
Microbio Co.,Ltd./Director
7.Company name of the mainland China enterprise and the
officer’s position in the enterprise:
Microbio (Shanghai) Co., Ltd./Chairman and Director
8.Address of the mainland China enterprise:
1188 Guangxing Road, Songjiang District, Shanghai
9.Operations of the mainland China enterprise:
Production and marketing of health capsules and tablets, processing of
Chinese herbal medicine,its extraction and Traditional Chinese Medicine
patent prescription and new drug research and development, etc.
10.Impact on the company’s finance and business:None.
11.If the directors have invested in the mainland China
enterprise, the monetary amount of the investment and
their shareholding ratio:
The direct and indirect investment amount from Microbio Co., Ltd. is
US 16,386,264 and the shareholding is 58.9%.
12.Any other matters that need to be specified:None.
|
||||
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.